Evidence map›Paper›PMID 31134321›Full record

ArticleMolecular genetics and genomics : MGG2019

Diversity of CRISPR/Cas system in Clostridium perfringens.

Jinzhao Long, Yake Xu, Liuyang Ou, Haiyan Yang, Yuanlin Xi, Shuaiyin Chen, Guangcai Duan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. AnMicroorganisms · 2025
    Article
  2. Article
  3. The CRISPR-Cas system inFrontiers in microbiology · 2024
    Article
  4. Article
  5. Correlation between CRISPR Loci Diversity in Three Enterobacterial Taxa.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Article
  8. First Comparative Analysis ofFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jinzhao LongDepartment of Epidemiology, College of Public Health, Zhengzhou University, No. 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China.
Yake XuSchool Hospital, Henan University of Science and Technology, Luoyang, Henan, People's Republic of China.
Liuyang OuDepartment of Epidemiology, College of Public Health, Zhengzhou University, No. 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China.
Haiyan YangDepartment of Epidemiology, College of Public Health, Zhengzhou University, No. 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China.
Yuanlin XiDepartment of Epidemiology, College of Public Health, Zhengzhou University, No. 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China.
Shuaiyin ChenDepartment of Epidemiology, College of Public Health, Zhengzhou University, No. 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China.
Guangcai DuanDepartment of Epidemiology, College of Public Health, Zhengzhou University, No. 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China. gcduan@yeah.net.
Zhengzhou University · CNHenan University of Science and Technology · CNXinxiang Medical University · CN

Funding

Henan Province University Science and Technology Innovation Talent Projects 17HASTIT045National Science and Technology Specific Projects 2013ZX10004607National Science and Technology Specific Projects 2018ZX10301407
6 · The paper itself

Abstract

Clostridium perfringens is an important pathogen of human and livestock infections, posing a threat to health. The horizontal gene transfer (HGT) of plasmids that carry toxin-related genes is involved in C. perfringens pathogenicity. The CRISPR/Cas system, which has been identified in a wide range of prokaryotes, provides acquired immunity against HGT. However, information about the CRISPR/Cas system in Clostridium perfringens is still limited. In this study, 111 C. perfringens strains with publicly available genomes were used to analyze the occurrence and diversity of CRISPR/Cas system and evaluate the potential of CRISPR-based genotyping in this multi-host pathogen. A total of 59 out of the 111 genomes harbored at least one confirmed CRISPR array. Four CRISPR/Cas system subtypes, including subtypes IB, IIA, IIC, and IIID systems, were identified in 32 strains. Subtype IB system was the most prevalent in this species, which was subdivided into four subgroups displaying subgroup specificity in terms of cas gene content, repeat sequence content, and PAM. We showed that the CRISPR spacer polymorphism can be used for evolutionary studies, and that it can provide discriminatory power for typing strains. Nevertheless, the application of this approach was largely limited to strains that contain the CRISPR/Cas system. Spacer origin analysis revealed that approximately one-fifth of spacers showed significant matches to plasmids and phages, thereby suggesting the implication of CRISPR/Cas systems in controlling HGT. Collectively, our results provide new insights into the diversity and evolution of CRISPR/Cas system in C. perfringens.

Indexed as

BacteriophagesClostridium perfringensClustered Regularly Interspaced Short Palindromic RepeatsComputational BiologyCRISPR-Cas SystemsGene Transfer, HorizontalGenome, BacterialPhylogenyPlasmidsPolymorphism, GeneticCas geneClostridium perfringensCRISPR/Cas systemGenotypingRepeatSpacer

Identifiers

PMID31134321
OpenAlexW2947415403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.